Column Group

Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are RAPT, ORIC, TNYA, NGM, Surrozen, and represent 100.00% of Column Group's stock portfolio.
  • Reduced shares in these 3 stocks: Surrozen (-$83M), RVMD (-$35M), EFTR.
  • Sold out of its position in EFTR.
  • Column Group was a net seller of stock by $-120M.
  • Column Group has $151M in assets under management (AUM), dropping by 0.51%.
  • Central Index Key (CIK): 0001833486

Tip: Access up to 7 years of quarterly data

Positions held by Column Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Column Group

Column Group holds 6 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Rapt Therapeutics (RAPT) 44.0 $67M 2.7M 24.85
 View chart
Oric Pharmaceuticals (ORIC) 21.7 $33M 3.6M 9.20
 View chart
Tenaya Therapeutics (TNYA) 20.1 $31M 9.4M 3.24
 View chart
Ngm Biopharmaceuticals (NGM) 10.3 $16M 18M 0.86
 View chart
Surrozen 3.9 $5.9M -93% 628k 9.40
 View chart
Revolution Medicines (RVMD) 0.0 $1.3k -99% 46.00 28.67
 View chart

Past Filings by Column Group

SEC 13F filings are viewable for Column Group going back to 2020